GGrantIndex
← Leaderboards

Mark T Hamann

University Of Mississippi

$5,667,987
Attributed
$7,241,494
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $698.5K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,241,494 · 10

By mechanism

R01$6,248,031 · 3
P20$390,618 · 3
K02$287,823 · 1
R21$252,000 · 1
P41$33,022 · 1
R13$30,000 · 1

Top collaborators

Others in their field

Top investigators on “Grant

Research focus

GrantStructurePharmaceutical PreparationsPoriferaProgramsInnovationIn VitroAnabolismInterestMethodologyCollaborationsDrug DiscoverySourceApplications GrantsDrug DevelopmentUniversitiesPlayRecording Of Previous EventsMarine OrganismIn VivoChemical StructureHigh Pressure Liquid ChromatographyMississippiPhylogenetic Analysis

Grant awards (28)

Synthesis and Optimization of the Aleutianamine Class of Alkaloids$527,418
R01 · FY2025 · GM · contact PI
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$530,142
R01 · FY2024 · GM · contact PI
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$43,500
R01 · FY2024 · GM · contact PI
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$532,866
R01 · FY2023 · GM · contact PI
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$165,660
R01 · FY2023 · GM · contact PI
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$560,675
R01 · FY2022 · GM · contact PI
Support for Graduate, PDF and New Faculty Presenters at the 2022 American Society of Pharmacognosy Meeting$30,000
R13 · FY2022 · AT · contact PI
Natural Product HCV Drugs from Rare Plant-Microbe Interactions$378,953
R01 · FY2016 · AT · contact PI
Natural Product HCV Drugs from Rare Plant-Microbe Interactions$298,115
R01 · FY2015 · AT · contact PI
Natural Product HCV Drugs from Rare Plant-Microbe Interactions$8,308
R01 · FY2015 · AT · contact PI
Natural Product HCV Drugs from Rare Plant-Microbe Interactions$306,423
R01 · FY2014 · AT · contact PI
Natural Product HCV Drugs from Rare Plant-Microbe Interactions$306,422
R01 · FY2013 · AT · contact PI
Natural Product HCV Drugs from Rare Plant-Microbe Interactions$326,900
R01 · FY2012 · AT · contact PI
MARINE CYSTINE KNOT PEPTIDES$33,022
P41 · FY2011 · RR · contact PI
CHEMISTRY CORE$84,159
P20 · FY2010 · RR · contact PI
CHEMISTRY CORE$128,191
P20 · FY2009 · RR · contact PI
CHEMISTRY CORE$178,268
P20 · FY2008 · RR · contact PI
ANTIAIDS AGENTS FROM MARINE ORGANISMS$336,448
R01 · FY2007 · AI · contact PI
ANTIAIDS AGENTS FROM MARINE ORGANISMS$346,497
R01 · FY2006 · AI · contact PI
ANTIAIDS AGENTS FROM MARINE ORGANISMS$354,835
R01 · FY2005 · AI
ANTIAIDS AGENTS FROM MARINE ORGANISMS$354,835
R01 · FY2004 · AI
ANTIAIDS AGENTS FROM MARINE ORGANISMS$322,875
R01 · FY2003 · AI
ANTIAIDS AGENTS FROM MARINE ORGANISMS$322,875
R01 · FY2002 · AI
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS$101,250
K02 · FY2002 · AI
ANTIAIDS AGENTS FROM MARINE ORGANISMS$224,284
R01 · FY2001 · AI
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS$94,665
K02 · FY2001 · AI
ANTIAIDS AGENTS FROM MARINE ORGANISMS$252,000
R21 · FY2000 · AI
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS$91,908
K02 · FY2000 · AI